Home › Trial NCT05797870
Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)
- Trial IDNCT05797870
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorCenter Eugene Marquis
- Enrollment16
- Start date2024-02-14
- ConditionsHepatocellular Carcinoma Non-resectable
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.